Overview - MTEM US

Molecular Templates Inc

MTEM.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

symbol	last	change	%chng	name	mcap	sector	wiki
MTEM				Molecular Templates Inc	0.012B	Healthcare

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
D	MTEM	1.70	0,-2.375,-2.714,-0.364,-2.375	3.69,3.68,3.61,3.52,3.66,4.00,3.87,3.62,2.86,1.85,2.32,1.91,1.90,1.60,1.57	1.94-3.47	58.84%	267,114,267	5.1	Jan 4-Sep 27	38.81%

Intraday chart for MTEM

Please reload the page if latest figures not showing

Key financials

The following extracted figures are selected by the AI as the most essential for predicting future price movements. The arrows show the how the AI thinks the figure affects the stock price (not the change in the figure)

. operatingIncome	-5M
. . netInterestIncome	0M
. incomeBeforeTax	-4M
. otherOperatingExpenses	12M
. netIncomeApplicableToCommonShares

. reconciledDepreciation	1M
. netWorkingCapital	-1M
. netInvestedCapital	4M
. netDebt	1M
. totalCashFromOperatingActivities	-5M
. freeCashFlow. .	-5M

News for MTEM

Fockups is back: funny mockup templates that offer a more realistic view of your designs - creativeboom
16:00 Fri - MTEM - story

headline news | recent news | latest news | market news

Chart MTEM

Similar stocks g.generic

Amneal Pharmaceuticals Inc. Class A Common Stock	AMRX	US	Healthcare	66.8547	1870M	-
Taro Pharmaceutical Industries Ltd	TARO	US	Healthcare	23.293	1583M	-
XOMA Corp	XOMA	US	Healthcare	48.949	280M	-
Curis Inc	CRIS	US	Healthcare	34.7793	94M	-
Endo International PLC	ENDP	US	Healthcare	73.9622	69M	-
Molecular Templates Inc	MTEM	US	Healthcare	47.018	12M	-
Lannett Company Inc	LCI	US	Healthcare	34.3145	7M	-
CytRx Corp	CYTR	US	Healthcare	21.4222	4M	-
Infinity Pharmaceuticals Inc	INFI	US	Healthcare	28.5405	1M	-

Myshare aims to provide good clear honest and easy analysis of financial markets using a scientific, teaching and informative approach. We try hard but please read our disclaimer. Pages are provided by ourselves and our users. Register to edit pages and see the documentation

Global news | headline news | recent news | latest news | market news | topics | stock topics

News topics and stories from around the world and in the selected country

US News | headline news | recent news | latest news | market news | recent topics | stock topics

News from major news outlets like BBC, CNN and Reuters

Forecasts | Forecast buy | Forecast sell | Forecast up | Forecast down | Forecast sector

Long term stock predictions using AI reading the financial accounts of each company.

``` ``` ``` ```